Prognyx oncology intelligence
Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.
使うべきか
品質と安全性
ツール定義とプロトコルへの準拠に関する自動分析に基づいています。
コンテキストコスト
これは、サーバーのツールがモデルのコンテキストに読み込まれるたびに消費されるおおよそのトークン数です。数が多いほど、ほかのタスクに使える注意が減ります。
インストール
ワンクリックインストール
これを `claude_desktop_config.json` ファイルに追加してください:
{
"mcpServers": {
"oncology-intelligence": {
"url": "https://www.prognyx.com/api/mcp"
}
}
}リモートエンドポイント
https://www.prognyx.com/api/mcpstreamable-httpできること
ツール一覧
ツール（3）
🟢compare_trials(asset, indication)
Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.
入力スキーマ
{
"type": "object",
"properties": {
"asset": {
"type": "string",
"maxLength": 80,
"description": "Public asset or target, e.g. \"sotorasib\", \"KRAS G12C\", \"B7-H3\"."
},
"indication": {
"type": "string",
"maxLength": 80,
"description": "Oncology indication, e.g. \"colorectal cancer\", \"NSCLC\"."
}
},
"required": [
"asset",
"indication"
],
"additionalProperties": false
}🟢search_registry(query, limit)
Live landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"maxLength": 160,
"description": "e.g. \"KRAS G12C\", \"Nuvalent\", \"claudin 18.2 gastric cancer\", \"NCT05132075\"."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 25,
"default": 10,
"description": "Studies to return."
}
},
"required": [
"query"
],
"additionalProperties": false
}🟢search_briefings(query, limit)
Prognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"maxLength": 120,
"description": "Drug, company, target or indication. Empty returns the latest."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 5,
"description": "Briefings to return."
}
},
"additionalProperties": false
}コミュニティ
エビデンス